CD8A and ovarian carcinoma: Using a humanized ovarian cancer model, DZNep-treated T cells were unable to control tumor metastasis to the same extent as control counterparts (33); similarly, CD8+ T cells transduced with a microRNA-26 decoy reduced tumor growth rate in an adoptive transfer melanoma model (32).